期刊文献+

CD4 T淋巴细胞计数与HIV感染者手术风险评估 被引量:29

CD4 T-Lymphocytes Count and Operation Risk Evaluation in Human Immunoddficiency Virus Positive Patients
原文传递
导出
摘要 目的根据CD4 T淋巴细胞计数评估HIV感染者手术并发症发生率的关系。方法回顾性分析上海公共卫生临床中心2009年1月-2010年3月收治的60例HIV阳性手术患者,按照不同CD4 T淋巴细胞计数分为A(CD4<100 cell/μl)、B(100 cell/μl<CD4<300 cell/μl)和C(CD4>300 cell/μl)三组。结果三组间术前白蛋白、血红蛋白、白细胞数量差异无统计学意义;A组术前HIV感染相关性并发症发生率为40%(6/15),术后甲级愈合率为66.7%(10/15),乙级愈合率为33.3%(5/15),手术死亡率为13.3%(2/15);其余二组Ⅰ类和Ⅱ类手术切口术前均无感染相关性并发症,术后伤口愈合均达到甲级,无手术死亡。结论 CD4 T淋巴细胞计数对HIV阳性患者的手术风险评估有重要意义,当CD4 T淋巴细胞计数<100 cell/μl时手术死亡率和感染性并发症发生率明显增加。 Objective To assess the relationship between postoperative infective complications and the different CD4 counts in patients with human immunoddficiency virus (HIV) infection. Methods The clinical materials of 60 cases with positive HIV coming from Shanghai Public Health Clinical Center from January 2009 to March 2010 were analyzed retrospective. CD4 T cell counts were divided into A( CD4 counts 〈 100 cell/μl) , B( 100 cell/μl 〈 CD4 counts 〈 300 cell/μl) and C( CD4 counts 〉 300 cell/μl) groups. Results The preoperative albumin, hemoglobin,white blood cell count were no significantly different among the three groups. In group A ,6 of 15 cases (40%) had preoperative HIV infection-associated complication, 10 cases (66.7%) had primary closure,cases(33.3% ) had secondary closure,and 2 cases( 13.3% ) died. The patients in other two groups of had no preoperative H1V infection-associated complication;all wounds had primary closure and there was no died case. Conclusion The CD4 cell count is important for the operation risk evaluation in HIV positive patients. Patients with a CD4 cell count of less than 100 probably are at greater risk of developing a postoperative infection and mortality during the postoperative period.
作者 刘立 刘保池
出处 《中华全科医学》 2011年第1期7-8,共2页 Chinese Journal of General Practice
基金 上海市公共卫生重点学科资助项目(08GWZX0103)
关键词 HIV CD4计数 感染性并发症 Human immunoddficiency virus CD4 cell count Infective complications
  • 相关文献

参考文献11

  • 1Samuel B. The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic[ J ]. Antiviral Research,2010,85 (1) :1- 18.
  • 2刘保池,刘立,李垒,陈辉,,卢洪洲.HIV感染者的外科治疗与医务人员职业暴露防护分析[J].中国全科医学,2010,13(4):448-449. 被引量:24
  • 3Kathryn A, Lee C, Carmen J,et al. Symptom Experience in HlV-Infected Aduhs:a function of demographic and clinical characteristics[ J]. Journal of Pain and Symptom Management,2009,386(6) :882-893.
  • 4臧国庆,吴良霞,余永胜,乐魏列,王伟卓.68例社区获得性肺炎病原及临床特征分析[J].实用全科医学,2004,2(5):457-458. 被引量:7
  • 5刘保池,刘立,陈辉,李垒,卢洪洲.HIV/AIDS外科合并症的手术治疗[J].国际外科学杂志,2009,36(9):602-605. 被引量:13
  • 6Jonathan K, Ernesto L, Kelley B, et al. Outcomes of human immunodeficiency virus-infected and-exposed children undergoing surgery-a prospective study[ J ]. Journal of Pediatric Surgery, 2009,44 ( 4 ) : 681- 687.
  • 7Ahmed SH. Role of thoracic surgery in patients suffering from Acquired Immune Deficiency Syndrome[ J ]. JR Coil Snrg. Edinb,2001, 46( 5 ) :257-260.
  • 8郜桂菊,张福杰,姚均,赵红心,卢联合,李鑫.HIV感染者/AIDS患者CD_4^+细胞计数与机会性感染对应关系的临床分析[J].中国艾滋病性病,2005,11(4):241-243. 被引量:87
  • 9Maria J,Jimenez E,Carlos A,et al: Mortality and morbidity in HlV-infected patients undergoing coronary artery bypass surgery:a case control study [ J ]. Rev Esp Cardiol,2006,59 ( 3 ) : 276-279.
  • 10Javier G, David H,Adams B, et al. Cardiovascular surgery in patients with HIV: epidemiology, current indications and long-term outcome [J]. Rev Esp Cardiol,2008,61 (5) :480-486.

二级参考文献21

  • 1龙宏纲,邝伟明,朱郇荣.AIDS病人施行外科手术的安全性评价[J].中国艾滋病性病,2004,10(3):185-186. 被引量:26
  • 2郭瑞章,刘保池.医务人员职业性暴露HIV的对策[J].世界急危重病医学杂志,2004,1(5):344-346. 被引量:22
  • 3姜贤政,张红梅.医护人员对HIV/AIDS的认识与接受态度的研究进展[J].中华实验和临床病毒学杂志,2004,18(3):297-298. 被引量:5
  • 4黄相刚,徐建青,任莉,仇超,张宁,刘连兴,万延民,彭虹,邵一鸣.人类免疫缺陷病毒DNA疫苗黏膜免疫小鼠免疫力研究[J].中华医学杂志,2006,86(44):3109-3113. 被引量:5
  • 5Batorova A, Martinowitz U. Continuous infusion of coagulation factors: current opinion[J]. Curr Opin Hematol, 2006, 13(5) :308- 315.
  • 6Cacciarelli AG, Naddaf SY, Zeftawy HA, et al. Acute chlecystitis in AIDS patients : correlation of TC - 99m hepatobiliary scintigraphy with histopathologic laboratory finding and CD4 count [J]. Clin Nucl Med, 1998, 23 (4): 226 - 228.
  • 7U. S. Public Health Service(USPHS) and Infectious Disease Society of America( IDSA). 2001 USPHA/IDSA guidelines for the prevention of opportunistic infected with human immunodeficiency virus [ J ].MMWR,2001,1 - 68.
  • 8Burman W, El-Sadr WE, Matts J, et al. Continued low rates of Mycobacterium avium complex and bacterial pneumonia despite withdrawal of azithromycin prophylaxis among patients with CD4^+ cell rebound[A]. Program and abstracts of the 9th Conference on Retroviruses and Opportunictic Infections [ C]. Seattle, Washington, February 24 -28,2002,631.
  • 9Yangco BG, Von Bargen JC, Moorman AC, et al. Can PCP prophylaxis be safely discontinued among clinically improving HIV patients[ C] ?[ Abstract I - 262 ]. 38th ICAAC, San Diego, CA, 1998.
  • 10Anglaret X, Chene G, Attia A, et al Early chemotherapy with trimethoprin-sulphamethoxazole for HIV-1 infected adults in Abidjan,Cote d' Ivoire: a randomised control trial[J ]. Lancet, 1999,353:1463-1468.

共引文献126

同被引文献214

引证文献29

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部